However, we found low heterogeneity between the five trials in all-cause mortality (I 2 = 22%) (Figure 2) and detected no heterogeneity between the two trials reporting heart failure (I 2 = 0%), unstable angina (I 2 = 0%), and myocardial reinfarction (I 2 = 0%) (Figure 3)
between 25 and 30, a person is overweight
Insulin resistance, de novo lipogenesis, and dysregulated blood glucose are key hallmarks in the progression of NAFLD as part of the multiple-hit hypothesis (39)
Though to our knowledge there are no studies on interactions between GLP-1 and CB1 receptors in the habenula, VTA or other brain regions, there is evidence of reciprocal functional interactions between these two receptors peripherally [57]
Glutamate modulation: In the next step, NAC modulates glutamate levels by influencing cysteine-glutamate exchange
Back Park, A (15 March 2024) 'GLP-1s on track to take drug sales throne from PD-1 inhibitors in 2024', Fierce Pharma